Contact: Ralph Barry, Chief Business Officer, Aegis Therapeutics LLC
1-858-618-1400 Ext. 102, Email: rbarry@aegisthera.com

Yearly Archives: 2008

Preclinical Study Presented at the International Congress of Endocrinology Shows Intravail® Drug Delivery Technology Provides Unmatched Non-Invasive Delivery of an Anti Obesity Peptide

SAN DIEGO, CA November 12, 2008/MarketWire/  Aegis Therapeutics LLC announced today that preclinical data was presented at the 2008 International Congress of Endocrinology in Rio de Janeiro, Brasil  demonstrating that its Intravail® formulation technology provides unmatched non-invasive delivery of the OB-3 peptide, a peptide previously shown to control weight gain and glucose levels in an […]

Aegis Therapeutics Awarded Patent for its ProTek® Room Temperature Stable Human Growth Hormone Formulations Suitable for Metered Nasal Spray Delivery

SAN DIEGO, CA September 16, 2008/MarketWire/– Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent 7,425,542, titled, “Stabilizing alkylglycoside compositions and methods thereof.”  The patent provides broad protection for stabilized human growth hormone (hGH) formulations.  Human growth hormone is a recombinant protein drug used in the treatment of pediatric and adult patients […]

Aegis Therapeutics to Present at the “4th Modern Drug Discovery & Development Summit” in San Diego, CA, October 15-17, 2008

SAN DIEGO, CA September 8, 2008/MarketWire/– Aegis Therapeutics, a drug delivery technology licensing company and leader in transmucosal drug delivery, will present a talk entitled: “Non-Invasive Peptide Delivery, Reformulation, and the Pharma Finance Environment” at the GTCbio “4th Modern Drug Discovery & Development Summit. The conference will be held on October 15-17, 2008, at the […]

Aegis Therapeutics to Present at the “13th Annual Drug Delivery Summit” in New Brunswick, NJ, September 22-23, 2008

SAN DIEGO, CA August 21, 2008/MarketWire/– Aegis Therapeutics, a drug delivery technology licensing company and leader in transmucosal drug delivery, will present a talk entitled: “New Technologies Expanding Practical Clinical Uses of Peptides, Proteins, and Other Macromolecular Therapeutics” at Insight’s “13th Annual Drug Delivery Summit”.  The conference will be held on September 22-23, 2008 at […]